about
Changes in Olfactory Bulb Volume in Parkinson's Disease: A Systematic Review and Meta-AnalysisRapid Eye Movement Sleep Behavior Disorder Symptoms Correlate with Domains of Cognitive Impairment in Parkinson's Disease.Long-term Levodopa Treatment Accelerates the Circadian Rhythm Dysfunction in a 6-hydroxydopamine Rat Model of Parkinson's Disease.Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy.Nrf2 signaling contributes to the neuroprotective effects of urate against 6-OHDA toxicity.Antioxidant activity of 7,8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity.Carvacrol, a food-additive, provides neuroprotection on focal cerebral ischemia/reperfusion injury in mice.Autophagic impairment contributes to systemic inflammation-induced dopaminergic neuron loss in the midbrain.Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland ChinaProtection effect of [Gly14]-Humanin from apoptosis induced by high glucose in human umbilical vein endothelial cells.Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake in Human Umbilical Vein Endothelial Cells via mTOR/NF-κB/LOX-1 Pathway.Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease.Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury.Elevated Serum Liver Enzymes in Patients with Obstructive Sleep Apnea-hypopnea Syndrome.A pivotal role of FOS-mediated BECN1/Beclin 1 upregulation in dopamine D2 and D3 receptor agonist-induced autophagy activation.Sonographic Alteration of Basal Ganglia in Different Forms of Primary Focal Dystonia: A Cross-sectional StudyAlteration of dynein function affects α-synuclein degradation via the autophagosome-lysosome pathway.Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of Parkinson's disease.Young Stroke Patients Treated with Intravenous Thrombolysis have a More Favorable Outcome and Mortality Compared with Older Patients.Statins upregulate cystathionine γ-lyase transcription and H2S generation via activating Akt signaling in macrophage.The risk factors and pattern of cerebral microbleeds in Parkinson's disease.A New Perspective for Parkinson's Disease: Circadian Rhythm.Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage.Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease.A natural coumarin derivative esculetin offers neuroprotection on cerebral ischemia/reperfusion injury in mice.The role of PARP activation in glutamate-induced necroptosis in HT-22 cells.Distribution of pancreatic B cell imaging agent (99m)Tc-DTPA-NGN2 in the body and animal experimental research on pancreatic B cell functional imaging.Role of autophagy and proteasome degradation pathways in apoptosis of PC12 cells overexpressing human alpha-synuclein.Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells.A case report and DSA findings of cerebral hemorrhage caused by syphilitic vasculitis.Prognostic Significance of Blood Urea Nitrogen in Acute Ischemic Stroke.Hyperfibrinogenemia is Significantly Associated with an Increased Risk of In-hospital Mortality in Acute Ischemic Stroke Patients.Rapamycin Promotes the Autophagic Degradation of Oxidized Low-Density Lipoprotein in Human Umbilical Vein Endothelial Cells.Monocyte to HDL cholesterol ratio is associated with discharge and 3-month outcome in patients with acute intracerebral hemorrhage.Analysis of pramipexole dose-response relationships in Parkinson's disease.Expression and functions of ASIC1 in the zebrafish retina.Tonic Electromyogram Density in Multiple System Atrophy with Predominant Parkinsonism and Parkinson's Disease.Sympathetic skin response and heart rate variability in predicting autonomic disorders in patients with Parkinson diseaseTranscranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
P50
Q26768485-7649C7EB-C184-4406-A40F-37BAFCB81008Q27302180-CF013C68-5D7A-4940-A77A-77F30747250EQ33646694-23C41B08-4BA7-4BDC-B859-6A7E0B7A7BE8Q33696105-2F87A03A-7D33-40E6-AF41-D72BAE38EF33Q33800053-E036910C-6C62-44FD-9E11-213417EE0C38Q34190581-256452A2-D92D-4335-A33E-0820303491DDQ34206309-456711AE-DCE6-4B9B-B443-34BEA1DAB9FEQ34925928-BA9D15F2-5EC6-4EEF-A525-931E7BBF701BQ35069101-D3ABC6AF-4AA7-4A09-A1C7-C805EA288528Q35468779-E45E3899-2519-4282-B465-F7149892A166Q35640718-D0BA26C2-9270-48AF-8AB4-FD8D5D9E94DEQ35890327-DBB3B42C-CAFD-42B3-AC70-F1F73EE54EDCQ36040485-8B141C14-2BA7-407A-9EB9-8B4382228CEEQ36141885-9C5F9102-4CE1-424D-8657-4B4662A04346Q36695944-84F82657-A77D-4C49-8B89-D2E9EDF7EDE6Q36777200-C80AE562-DE8D-49BA-8E32-09E752DFE9AFQ36797812-3E813408-BFCD-4810-BAF4-0E5CBF360E90Q37420985-761DE9BF-DD72-4446-8F37-2BC292AD3AE9Q37635829-008285BF-099D-4D91-98EC-D76505979396Q38868604-CFB90271-B73C-417E-9E67-97E59A79DE60Q38982483-B2273C7F-0F98-4599-B903-D3E338AE0682Q39041267-B8B71F85-450A-4227-9759-F3A504C9C80AQ39044244-E59E1B15-7A5B-4872-843E-5C485A487885Q39122959-D3C0D57D-7907-46DB-A8E5-353B6E68AED9Q39570564-D205339D-1845-4F32-BC05-9482DE78D597Q39635298-C6E6A37D-5124-4FAD-961B-BCA5E1DA8FFAQ39706382-65D2E6F7-72DE-4D31-B364-9B8C6C67FB71Q39761140-4AA68F7F-16AC-42CA-BAA4-42415DAA9D7DQ39853847-1B455740-D880-4A0F-9270-C2581C997B71Q40002308-380E7C5D-17BA-4F94-9F49-656752612F8DQ40013691-9156A069-C3FD-47F3-BB14-A5ED8D644546Q40042332-1597CA47-04DF-4852-B0EB-7878924E4378Q40150847-E5CB68D1-F978-42C4-A255-6D647E4B6EFEQ40256645-62FB8994-62D6-4552-B829-B0E752F22405Q40408349-7644C70D-8C37-4501-BB8F-0FD96F5CC142Q40567300-8930FB12-C845-4414-BA17-297322EF04E2Q41759736-DB897F9E-CDF2-430A-AF30-96BE86BA6702Q41876579-A9EF3340-11CC-4F6F-B245-9976BEF3C473Q42116670-305AE5CC-55AB-4B0B-83CC-1D03B5959706Q42209851-1F8B3BF5-C865-4BBB-8F18-C4C10ECA5CEB
P50
name
Chun-Feng Liu
@ast
Chun-Feng Liu
@en
Chun-Feng Liu
@nl
type
label
Chun-Feng Liu
@ast
Chun-Feng Liu
@en
Chun-Feng Liu
@nl
prefLabel
Chun-Feng Liu
@ast
Chun-Feng Liu
@en
Chun-Feng Liu
@nl